Home › Glioblastoom › North Carolina › Durham
Glioblastoom klinische studies in Durham, NC
20 studies voor Glioblastoom zoeken deelnemers op locaties in en rond Durham (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM
RekruterenFase 3
- University of North Carolina, Chapel Hill · 10 mijl verwijderd
Targeted Pediatric High-Grade Glioma Therapy
RekruterenObservatieonderzoek
- Duke University Health System, Durham
Study of Olutasidenib and Temozolomide in HGG
RekruterenFase 2
- Duke University Health System, Durham
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
RekruterenFase 3
- Duke Cancer Institute, Durham
BRiTE - Bispecific T Cell Engager for Patients With Glioblastoma
RekruterenFase 1
- Duke University Medical Center, Durham
Identifying Findings on Brain Scans That Could Help Make Better Predictions About Brain Cancer Progression, The GABLE Trial
RekruterenFase 2
- Duke University Medical Center, Durham
A Phase 2 Study of the Ketogenic Diet vs Standard Anti-cancer Diet Guidance for Patients With Glioblastoma in Combination With Standard-of-care Treatment
RekruterenFase 2
- Duke University, Durham
A Multicenter Trial to Identify Optimal Atezolizumab Biomarkers in the Setting of Recurrent Glioblastoma. The MOAB Trial
RekruterenFase 2
- Duke University, Durham
Lerapolturev (PVSRIPO) in GBM
RekruterenFase 2
- Duke University Medical Center, Durham
DOC1021 Dendritic Cell Immunotherapy for Treatment of Newly Diagnosed Adult Glioblastoma (GBM)
RekruterenFase 2
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mijl verwijderd
Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
RekruterenVroege fase 1Gezonde vrijwilligers welkom
- Duke University Health System, Durham
Phase 1 Trial of D2C7-IT in Combination With 2141-V11 for Recurrent Malignant Glioma
RekruterenFase 1
- Duke University Medical Center, Durham
Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
RekruterenFase 2
- Duke University Health System, Durham
Autologous CAR-T Cells Targeting B7-H3 in Recurrent or Refractory GBM CAR.B7-H3Tc
RekruterenFase 1
- Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mijl verwijderd
Key Longitudinal Associations With Risk and Glioblastoma Outcomes
RekruterenObservatieonderzoek
- Duke University, Durham
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruterenObservatieonderzoek
- Massive Bio SYNERGY-AI site, Chapel Hill · 10 mijl verwijderd
D2C7-IT + 2141-V11 Combination Post-resection in rGBM
RekruterenFase 1
- Duke University Medical Center, Durham
D2C7-IT and 2141-V11 in Newly Diagnosed GBM Patients
RekruterenFase 1/2
- Duke University Medical Center, Durham
APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
RekruterenFase 2
- University of North Carolina, Chapel Hill · 10 mijl verwijderd
Evaluation of Eflornithine Plus Temozolomide in Patients With Newly Diagnosed Glioblastoma or Astrocytoma
RekruterenFase 1
- Duke University, Durham
Glioblastoom studies in andere steden
- New York City, NY30 studies
- Boston, MA28 studies
- Houston, TX26 studies
- Los Angeles, CA24 studies
- San Francisco, CA17 studies
- Chicago, IL15 studies
- Washington, DC15 studies
- Columbus, OH14 studies
- Miami, FL14 studies
- Rochester, MN13 studies
- Jacksonville, FL13 studies
- Aurora, CO12 studies
Andere studies in Durham
- Borstkanker64 studies
- Kanker (alle vormen)58 studies
- Niet-kleincellige longkanker39 studies
- Multipel myeloom37 studies
- Acute myeloïde leukemie33 studies
- Metastatische kanker33 studies
- Prostaatkanker32 studies
- Longkanker32 studies
- Colorectale kanker28 studies
- Eierstokkanker27 studies
- Chronische lymfatische leukemie27 studies
- Hartfalen26 studies
Van ClinicalTrials.gov, gegevens opgehaald op 6 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.